Search for Clinical Trial Results

Sponsored By

Adrenal Cortex Neoplasms - 12 Studies Found

Status Study
Completed Study Name: Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
Condition: Adrenocortical Carcinoma
Date: 2012-02-05
Interventions:
  • Genetic: DNA methylation analysis
  • Genetic:
Active, not recruiting Study Name: Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Condition:
  • Stage I Adrenocortical Carcinoma
  • Stage II Adrenocortical Carcinoma
  • Drug: doxorubicin hydrochloride

Active, not recruiting Study Name: Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Condition:
  • Adrenocortical Carcinoma
  • Peritoneal Carcinomatosis

Date: 2013-04-12
Interventions:
  • Drug: Cisplatin Patients who a
Completed Study Name: Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2011-12-21
Interventions: Drug: Dovitinib Dovitinib (TKI-258), gelatin capsule of 10
Completed Study Name: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2009-06-17
Interventions:
  • Drug: OSI-906 Administered ora
Completed Study Name: Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Condition:
  • Recurrent Adrenocortical Carcinoma
  • Stage III Adrenocortical Carcinoma
  • Drug: Sorafenib Treatment sche
Terminated Study Name: IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
Condition:
  • Recurrent Adrenocortical Carcinoma
  • Stage III Adrenocortical Carcinoma
  • Biological: IMC-A12 Given IV
Recruiting Study Name: Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Condition: Adrenocortical Carcinoma
Date: 2008-10-21
Interventions: Drug: MITOTANE mitotane will be administered at a starting dose of 1.5 g/day and increased in case of go
Withdrawn Study Name: Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2007-05-02
Interventions: Drug: Bevacizumab
Next >>>